LaserSight denies device patent infringement -- debuts Auto-PRK at ASCRS Convention.ORLANDO, Fla--(BUSINESS WIRE)--March 31, 1995--In response to the announcement by Pillar Point Partners that it has filed a suit against LaserSight (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :LASE) for patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. , LaserSight denies any device patent infringements. Robert Qualls, Chief Executive Officer, said, "Our patent counsel is of the opinion that we are not infringing device patents. We haven't yet seen the suit, and the filing was made public before we were served. It is also the Company's understanding that in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Federal law exempts investigational devices from patent claims." LaserSight has experienced tremendous success in international sales, as demonstrated by an increase in net income to $1,018,431 in 1994 from a loss of $4,752,613 in 1993. Audited financial statements were filed as part of LaserSight's Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. with the Securities and Exchange Commission yesterday, March 30, 1995. LaserSight will be demonstrating its revolutionary integrated tracking delivery system this week at the annual meeting of the American Society of Cataract and Implant Surgeons, San Diego, April 1st through April 5th. Unlike excimer lasers produced by the Pillar Point Partners (Summit and VISX) the LaserSight Mini-Excimer features a fully-integrated tracking delivery system allowing for complete automation of the PRK PRK photorefractive keratectomy. Photorefractive keratectomy (PRK) A procedure that uses an excimer laser to make modifications to the cornea and permanently correct myopia. procedure. The Company expects Auto-PRK to provide unprecedented standardization of results. CONTACT: LaserSight Robert Qualls, Chief Executive Officer 314/469-3220 or Gregory L. Wilson, Chief Financial Officer 314/469-3220 or Marti Benfield, Investor Relations Investor relations The process by which the corporation communicates with its investors. 314/469-3220 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion